Latest news with #FudanUniversity
Yahoo
7 hours ago
- Health
- Yahoo
Liver cancer cases could double by 2050. A new study says 60% are preventable
Liver cancer is on the rise, but experts say it doesn't have to be this way. A new analysis published by an expert panel on liver cancer has shown that three out of five liver cancer cases worldwide are linked to preventable risk factors. These include viral hepatitis, alcohol consumption, and an increasingly common but often overlooked threat: obesity-related liver disease. Without urgent intervention, the number of liver cancer cases is expected to nearly double from 870,000 in 2022 to 1.52 million by 2050, with annual deaths rising from 760,000 to 1.37 million. But experts argue that millions of lives can be saved with targeted prevention and policy reforms. Liver cancer "is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent,' said Jian Zhou, a professor at Fudan University in China and chair of the Lancet commission. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend,' Zhou said in a statement. A shifting landscape of risk Traditionally associated with hepatitis infections and heavy alcohol use, liver cancer is now being increasingly driven by metabolic dysfunction-associated steatotic liver disease (MASLD), once commonly known as non-alcoholic fatty liver disease. MASLD is one of the most common liver conditions in Europe, affecting up to 25 per cent of the adult population, Beatrice Credi of the European Liver Patients' Association (ELPA) told Euronews Health. 'It is crucial to stress that while these risk factors are prevalent, they are often preventable or manageable with appropriate intervention,' she added, emphasising the importance of education as well as robust public health campaigns. This long-term liver condition is linked to obesity and poor metabolic health. Its more severe form, known as MASH (metabolic dysfunction-associated steatohepatitis), is the fastest-growing cause of liver cancer globally. Related Global obesity rates are surging as people gain weight younger and faster than in the past The Lancet commission projects that liver cancers linked to MASH will increase by 35 per cent, rising from 8 per cent of cases in 2022 to 11 per cent by 2050. Liver cancers related to alcohol are also expected to rise modestly. Meanwhile, cases caused by hepatitis B and C are predicted to decline slightly thanks to vaccination and improved treatment efforts. Numbers are particularly concerning in high-income countries, where obesity rates are soaring. In the United States, MASLD is expected to affect more than half of all adults by 2040, dramatically increasing liver cancer risk. According to Dr Hashem El-Serag, a professor at Baylor College of Medicine, the profile of the disease is evolving. 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease,' he said. But with obesity on the rise, it is becoming an increasingly prominent risk factor, largely due to growing cases of excess liver fat. The prevention opportunity Despite the grim projections, the Lancet commission offers a glimmer of hope: the potential of prevention. If new liver cancer cases are reduced by 2 per cent to 5 per cent each year, it could prevent up to 17 million new cases and save as many as 15 million lives by 2050. Related EU can dodge millions of cancers by hitting tobacco, alcohol reduction targets, study claims Achieving that would require a multi-pronged global effort, including expanding hepatitis B vaccination and universal adult HBV screening, as well as tackling obesity and alcohol misuse through taxes, warning labels, and better food and beverage policies. The Lancet commission also suggests integrating liver screening into routine care for people with obesity, diabetes, and heart disease and investing in public education and early detection tools. 'As three in five cases of liver cancer are linked to preventable risk factors ... there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer, and save lives,' said Stephen Chan, lead author of the study and a professor ar the Chinese University of Hong Kong. A global call to action In Europe, recent policy shifts have increasingly emphasised prevention and early detection. The European Union's Beating Cancer Plan aims to achieve 95 per cent coverage for childhood hepatitis B vaccination and screening of pregnant women by 2030. It also encourages healthier lifestyle choices and aims to reduce exposure to known risk factors such as alcohol, tobacco, obesity, and diabetes. Related Weight-loss drugs like Wegovy could help serious liver condition that has no cure-all treatment A policy recommendation issued by the European Commission in January called for expanded uptake of preventive vaccines (specifically HPV and hepatitis B) and improved monitoring of vaccine coverage rates. But in the fight against liver cancer, the EU must also confront a less visible but equally powerful force: the commercial determinants of health, said ELPA's Beatrice Credi. 'Industries that profit from the sale of alcohol, unhealthy foods, and tobacco play a significant role in driving some of the liver cancer risk factors. Our policymakers must prioritise public health,' she told Euronews Health. She noted, however, that policies aimed at regulating these commercial influences remain weak or inconsistently enforced across the EU, with the only exception of taxes on sugar-sweetened beverages. Related Millions in Europe unknowingly living with hepatitis, health authorities warn Prevention alone is not enough. As more people are now living with liver cancer than ever before, the Lancet commission stressed the urgent need for improved care, earlier diagnosis, and better support for patients—especially in regions such as Africa and Asia, where the disease burden is highest and health care resources are limited. But Valérie Paradis, a professor at Beaujon Hospital in France, suggested effective prevention could also help ease that burden. 'Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies,' Paradis said.
Yahoo
a day ago
- Health
- Yahoo
Liver cancer cases could double by 2050. A new study says 60% are preventable
Liver cancer is on the rise, but experts say it doesn't have to be this way. A new analysis published by an expert panel on liver cancer has shown that three out of five liver cancer cases worldwide are linked to preventable risk factors. These include viral hepatitis, alcohol consumption, and an increasingly common but often overlooked threat: obesity-related liver disease. Without urgent intervention, the number of liver cancer cases is expected to nearly double from 870,000 in 2022 to 1.52 million by 2050, with annual deaths rising from 760,000 to 1.37 million. But experts argue that millions of lives can be saved with targeted prevention and policy reforms. Liver cancer "is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent,' said Jian Zhou, a professor at Fudan University in China and chair of the Lancet commission. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend,' Zhou said in a statement. A shifting landscape of risk Traditionally associated with hepatitis infections and heavy alcohol use, liver cancer is now being increasingly driven by metabolic dysfunction-associated steatotic liver disease (MASLD), once commonly known as non-alcoholic fatty liver disease. MASLD is one of the most common liver conditions in Europe, affecting up to 25 per cent of the adult population, Beatrice Credi of the European Liver Patients' Association (ELPA) told Euronews Health. 'It is crucial to stress that while these risk factors are prevalent, they are often preventable or manageable with appropriate intervention,' she added, emphasising the importance of education as well as robust public health campaigns. This long-term liver condition is linked to obesity and poor metabolic health. Its more severe form, known as MASH (metabolic dysfunction-associated steatohepatitis), is the fastest-growing cause of liver cancer globally. Related Global obesity rates are surging as people gain weight younger and faster than in the past The Lancet commission projects that liver cancers linked to MASH will increase by 35 per cent, rising from 8 per cent of cases in 2022 to 11 per cent by 2050. Liver cancers related to alcohol are also expected to rise modestly. Meanwhile, cases caused by hepatitis B and C are predicted to decline slightly thanks to vaccination and improved treatment efforts. Numbers are particularly concerning in high-income countries, where obesity rates are soaring. In the United States, MASLD is expected to affect more than half of all adults by 2040, dramatically increasing liver cancer risk. According to Dr Hashem El-Serag, a professor at Baylor College of Medicine, the profile of the disease is evolving. 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease,' he said. But with obesity on the rise, it is becoming an increasingly prominent risk factor, largely due to growing cases of excess liver fat. The prevention opportunity Despite the grim projections, the Lancet commission offers a glimmer of hope: the potential of prevention. If new liver cancer cases are reduced by 2 per cent to 5 per cent each year, it could prevent up to 17 million new cases and save as many as 15 million lives by 2050. Related EU can dodge millions of cancers by hitting tobacco, alcohol reduction targets, study claims Achieving that would require a multi-pronged global effort, including expanding hepatitis B vaccination and universal adult HBV screening, as well as tackling obesity and alcohol misuse through taxes, warning labels, and better food and beverage policies. The Lancet commission also suggests integrating liver screening into routine care for people with obesity, diabetes, and heart disease and investing in public education and early detection tools. 'As three in five cases of liver cancer are linked to preventable risk factors ... there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer, and save lives,' said Stephen Chan, lead author of the study and a professor ar the Chinese University of Hong Kong. A global call to action In Europe, recent policy shifts have increasingly emphasised prevention and early detection. The European Union's Beating Cancer Plan aims to achieve 95 per cent coverage for childhood hepatitis B vaccination and screening of pregnant women by 2030. It also encourages healthier lifestyle choices and aims to reduce exposure to known risk factors such as alcohol, tobacco, obesity, and diabetes. Related Weight-loss drugs like Wegovy could help serious liver condition that has no cure-all treatment A policy recommendation issued by the European Commission in January called for expanded uptake of preventive vaccines (specifically HPV and hepatitis B) and improved monitoring of vaccine coverage rates. But in the fight against liver cancer, the EU must also confront a less visible but equally powerful force: the commercial determinants of health, said ELPA's Beatrice Credi. 'Industries that profit from the sale of alcohol, unhealthy foods, and tobacco play a significant role in driving some of the liver cancer risk factors. Our policymakers must prioritise public health,' she told Euronews Health. She noted, however, that policies aimed at regulating these commercial influences remain weak or inconsistently enforced across the EU, with the only exception of taxes on sugar-sweetened beverages. Related Millions in Europe unknowingly living with hepatitis, health authorities warn Prevention alone is not enough. As more people are now living with liver cancer than ever before, the Lancet commission stressed the urgent need for improved care, earlier diagnosis, and better support for patients—especially in regions such as Africa and Asia, where the disease burden is highest and health care resources are limited. But Valérie Paradis, a professor at Beaujon Hospital in France, suggested effective prevention could also help ease that burden. 'Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies,' Paradis said.
Euronews
a day ago
- Health
- Euronews
Liver cancer cases could double by 2050, but 60% are preventable
Liver cancer is on the rise, but experts say it doesn't have to be this way. A new analysis published by an expert panel on liver cancer has shown that three out of five liver cancer cases worldwide are linked to preventable risk factors. These include viral hepatitis, alcohol consumption, and an increasingly common but often overlooked threat: obesity-related liver disease. Without urgent intervention, the number of liver cancer cases is expected to nearly double from 870,000 in 2022 to 1.52 million by 2050, with annual deaths rising from 760,000 to 1.37 million. But experts argue that millions of lives can be saved with targeted prevention and policy reforms. Liver cancer "is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent,' said Jian Zhou, a professor at Fudan University in China and chair of the Lancet commission. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend,' Zhou said in a statement. A shifting landscape of risk Traditionally associated with hepatitis infections and heavy alcohol use, liver cancer is now being increasingly driven by metabolic dysfunction-associated steatotic liver disease (MASLD), once commonly known as non-alcoholic fatty liver disease. MASLD is one of the most common liver conditions in Europe, affecting up to 25 per cent of the adult population, Beatrice Credi of the European Liver Patients' Association (ELPA) told Euronews Health. 'It is crucial to stress that while these risk factors are prevalent, they are often preventable or manageable with appropriate intervention,' she added, emphasising the importance of education as well as robust public health campaigns. This long-term liver condition is linked to obesity and poor metabolic health. Its more severe form, known as MASH (metabolic dysfunction-associated steatohepatitis), is the fastest-growing cause of liver cancer globally. The Lancet commission projects that liver cancers linked to MASH will increase by 35 per cent, rising from 8 per cent of cases in 2022 to 11 per cent by 2050. Liver cancers related to alcohol are also expected to rise modestly. Meanwhile, cases caused by hepatitis B and C are predicted to decline slightly thanks to vaccination and improved treatment efforts. Numbers are particularly concerning in high-income countries, where obesity rates are soaring. In the United States, MASLD is expected to affect more than half of all adults by 2040, dramatically increasing liver cancer risk. According to Dr Hashem El-Serag, a professor at Baylor College of Medicine, the profile of the disease is evolving. 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease,' he said. But with obesity on the rise, it is becoming an increasingly prominent risk factor, largely due to growing cases of excess liver fat. The prevention opportunity Despite the grim projections, the Lancet commission offers a glimmer of hope: the potential of prevention. If new liver cancer cases are reduced by 2 per cent to 5 per cent each year, it could prevent up to 17 million new cases and save as many as 15 million lives by 2050. Achieving that would require a multi-pronged global effort, including expanding hepatitis B vaccination and universal adult HBV screening, as well as tackling obesity and alcohol misuse through taxes, warning labels, and better food and beverage policies. The Lancet commission also suggests integrating liver screening into routine care for people with obesity, diabetes, and heart disease and investing in public education and early detection tools. 'As three in five cases of liver cancer are linked to preventable risk factors ... there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer, and save lives,' said Stephen Chan, lead author of the study and a professor ar the Chinese University of Hong Kong. A global call to action In Europe, recent policy shifts have increasingly emphasised prevention and early detection. The European Union's Beating Cancer Plan aims to achieve 95 per cent coverage for childhood hepatitis B vaccination and screening of pregnant women by 2030. It also encourages healthier lifestyle choices and aims to reduce exposure to known risk factors such as alcohol, tobacco, obesity, and diabetes. A policy recommendation issued by the European Commission in January called for expanded uptake of preventive vaccines (specifically HPV and hepatitis B) and improved monitoring of vaccine coverage rates. But in the fight against liver cancer, the EU must also confront a less visible but equally powerful force: the commercial determinants of health, said ELPA's Beatrice Credi. 'Industries that profit from the sale of alcohol, unhealthy foods, and tobacco play a significant role in driving some of the liver cancer risk factors. Our policymakers must prioritise public health,' she told Euronews Health. She noted, however, that policies aimed at regulating these commercial influences remain weak or inconsistently enforced across the EU, with the only exception of taxes on sugar-sweetened beverages. Prevention alone is not enough. As more people are now living with liver cancer than ever before, the Lancet commission stressed the urgent need for improved care, earlier diagnosis, and better support for patients—especially in regions such as Africa and Asia, where the disease burden is highest and health care resources are limited. But Valérie Paradis, a professor at Beaujon Hospital in France, suggested effective prevention could also help ease that burden. 'Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies,' Paradis said.
Arab Times
a day ago
- Health
- Arab Times
New study finds 60% of liver cancer cases are preventable
LONDON, July 29: Liver cancer is poised to become a significantly larger global health challenge, particularly affecting younger adults, with cases expected to double by 2050, experts warn. Previously viewed mainly as a disease impacting older individuals with hepatitis infections or alcohol dependency, liver cancer is increasingly being diagnosed in people in their 30s and 40s. A major new analysis published in The Lancet attributes this shift to the rise in obesity and related liver conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD). The report predicts new liver cancer cases worldwide will increase from 870,000 in 2022 to 1.52 million by 2050, with annual deaths rising from 760,000 to 1.37 million during the same period. One of the fastest-growing causes is metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease linked to obesity and metabolic dysfunction. The proportion of liver cancers connected to MASH is expected to more than double — from 5% in 2022 to 11% in 2050. Cases caused by the most common causes of liver cancer — the hepatitis B and C viruses—are predicted to decline. However, cases related to obesity and alcohol consumption are expected to increase. By 2050, over a fifth of liver cancer cases will be attributed to alcohol, while one in ten will be caused by severe MASLD, formerly known as fatty liver disease. This condition occurs when fat accumulates in the liver and is closely associated with obesity and type 2 diabetes. Researchers from Hong Kong emphasized that 60% of liver cancer cases are preventable. Their findings underscore the urgent need for preventative measures against liver cancer, also called hepatocellular carcinoma. The primary treatment for MASLD involves maintaining a balanced diet, engaging in physical activity, and potentially losing weight. "Liver cancer is a growing health issue worldwide," said Professor Jian Zhou, chairman of the Commission from Fudan University in China. "It is one of the most challenging cancers to treat, with five-year survival rates ranging from about 5% to 30%. Without urgent action, we risk nearly doubling the number of cases and deaths over the next 25 years." Professor Stephen Chan, lead author of the study from the Chinese University of Hong Kong, added: "There is a significant opportunity for countries to target these risk factors, prevent liver cancer cases, and save lives." Pamela Healy, chief executive of the British Liver Trust, commented on the study: "Liver cancer is the fastest-rising cause of cancer death in the UK, with only 13% of people diagnosed surviving for five years or more. The main risk factors are pre-existing liver cirrhosis or viral hepatitis, and this analysis highlights that MASLD, also known as fatty liver disease, is linked to an increasing number of cases." Liver cirrhosis is a progressive condition that can lead to liver failure if untreated, characterized by permanent scarring due to long-term damage. "Along with improving early detection through monitoring those with cirrhosis, it is vital to address the underlying causes and prioritize public health efforts," Healy said. "By helping people maintain a healthy weight, reduce alcohol intake, and get tested and treated for hepatitis, many liver cancer cases can be prevented." In the UK, there is growing urgency to tackle the obesity crisis to ease pressure on the National Health Service. Recent data shows nearly two-thirds of adults in England are overweight, with an additional 260,000 people joining this group last year. Meanwhile, more than a quarter (26.5%)—about 14 million people—are classified as obese. Last month, GPs were authorized to prescribe weight loss injections, known as GLP-1s, for the first time to address the crisis. Approximately 1.5 million people are currently using these injections through the NHS or private clinics, with millions more eligible. However, pharmacists have warned that the rising demand may become unsustainable.
Observer
a day ago
- Health
- Observer
Liver cancer to double worldwide, but preventable: Study
Paris - The number of people with liver cancer will nearly double worldwide by 2050 unless more is done to address preventable causes such as obesity, alcohol consumption, and hepatitis, a study warned Tuesday. New cases of liver cancer -- the sixth most common form of the disease -- will rise to 1.52 million a year from 870,000 if current trends continue, according to data from the Global Cancer Observatory published in the Lancet medical journal. It is also the third deadliest of all cancers, with the study predicting it would take 1.37 million lives by the middle of the century. However, three out of five cases of liver cancer could be prevented, the international team of experts said. The risk factors are drinking alcohol, viral hepatitis, and a build-up of fat in the liver linked to obesity called MASLD, which was previously known as non-alcoholic fatty liver disease. The viruses that cause hepatitis B and C are expected to remain the leading causes of liver cancer in 2050, according to the study, published on World Hepatitis Day. Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said. Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added. Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022. Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated. The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said. The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia. The commission, led by Jian Zhou from Fudan University in Shanghai, also proposed measures to reduce the number of hepatocellular carcinoma cases by 2% to 5% annually." "Asia, particularly affected The commission analysed hundreds of studies on hepatocellular carcinoma and developed projections for its increase up to 2050across different world regions. It also considered factors such as population, ageing, and the prevalence of hepatitis infections, which can contribute to the disease. The focus was on this specific type of liver cancer, which originates in liver cells, while other types of liver cancer were excluded. The commission predicts an increase in annual new cases of hepatocellular carcinoma from 0.87 million in 2022 to 1.52 million in 2050, representing a 76% rise. The highest numbers, both today and in 2050, are expected in Asia, where more than 70% of all global cases occur. The largest increase, albeit from a low starting point, is anticipated in Africa, with an increase of approximately 145%. Europe is projected to see the most favourable trend among all continents, with annual new cases rising by 30% and deaths by 36% 2050. Liver cancer is often linked to preventable risk factors A significant proportion of hepatocellular carcinoma cases could be prevented, the commission stated. Around 60% of cases are caused by known risk factors: the viral infections hepatitis B and hepatitis C, as well as alcoholic and non-alcoholic fatty liver disease. The commission expects varying trends for these causes by 2050. Whilethe share of cases linked to viral infections is expected to declineslightly - hepatitis B from 39% to 37% and hepatitis C from 29% to26% - the proportion of cases due to alcoholic fatty liver disease isprojected to rise from 19% to 21%, and those caused byobesity-related fatty liver disease from 8% to 11%." As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer, and save lives," said lead author Stephen LamChan from the Chinese University in Hong Kong . The commission recommends, among other measures, increasing hepatitis B vaccinations and testing adults for hepatitis C to enable early treatment. Additionally, alcoholic beverages should carry warning labels, become more expensive, and advertising for them should be banned. Regular liver screenings should also be conducted for individuals in high-risk groups. According to Germany's Centre for Cancer Registry Data at the RobertKoch Institute (RKI), approximately 5,700 people in Germany are newly diagnosed with hepatocellular carcinoma each year, out of a total of 9,800 liver cancer cases. Men are more than twice as likely to develop liver cancer as women. For both genders, the median five-year survival rate is about 17%. Symptoms of liver cancer, according to German Cancer Aid, include general weakness, tenderness in the upper right abdomen, unexplained weight loss, fluid accumulation in the abdominal cavity, and yellowing of the skin and eyes.
